Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.4.0.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Income Statement [Abstract]    
Net revenues:
Operating expenses:    
Research and development $ 1,357 $ 2,477
General and administrative 1,295 4,061
Total operating costs and expenses 2,652 6,538
Loss from operations (2,652) (6,538)
Other income (expense):    
Interest Expense (1,278) $ (42)
Change in fair value of warrants & derivatives liabilities 2,459
Change in fair value of share-settled debt 20
Loss on extinguishment of convertible debt (74)
Other expense (51)
Total other income (expense) 1,076 $ (42)
Net loss (1,576) (6,580)
Dividends declared on convertible preferred stock (749) $ (828)
Deemed dividends on convertible preferred stock (10,307)
Net loss applicable to common stockholders $ (12,632) $ (7,408)
Net loss per share applicable to common stockholders - basic and diluted $ (0.37) $ (1.02)
Weighted average shares used in computing basic and diluted loss per share 33,720,000 7,232,000